Quinoxaline N,N′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 14, 2004, Pages 3835-3839

  Aguirre, Gabriela ^a   Cerecetto, Hugo ^a   Di Maio, Rossanna ^a   González, Mercedes ^a   Alfaro, María Elena Montoya ^b   Jaso, Andrés ^c   Zarranz, Belén ^c   Ortega, Miguel Ángel ^c   Aldana, Ignacio ^c   Monge Vega, Antonio ^c  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Anti parasitic agents; Growth inhibitors; Trypanosoma cruzi

Indexed keywords

CYTOTOXIC AGENT; GROWTH INHIBITOR; NIFURTIMOX; QUINOXALINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; GROWTH INHIBITION; IN VITRO STUDY; LIPOPHILICITY; MICROBIAL GROWTH; NONHUMAN; PHYSICAL CHEMISTRY; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRYPANOSOMA CRUZI;

ANIMALS; CHEMISTRY, PHYSICAL; CYCLIC N-OXIDES; DATA INTERPRETATION, STATISTICAL; NIFURTIMOX; PARASITIC SENSITIVITY TESTS; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 2942532638     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.04.088     Document Type: Article

References (44)

1. http://www.who.int/ctd/chagas
2. Moncayo, A. In Eleventh Programme Report of the UNPD: World Bank: WHO Special Program for Research and Training in Tropical Diseases (TDR), Geneva: World Health Organization, 1993; pp 67-75
3. De Souza W. Curr. Pharm. Des. 4:2002;269-285
4. Faucher J.F., Baltz T., Petry K.G. Parasitol. Res. 81:1995;441-443
5. Almeida-de-Faria M., Freymuller E., Colli W., Alves M.J. Exp. Parasitol. 92:1999;263-274
6. Tyler K.M., Engman D.M. Int. J. Parasitol. 31:2001;472-481
7. Cazzulo J.J. Curr. Top. Med. Chem. 2:2002;1261-1271
8. Schmidt A., Krauth-Siegel R.L. Curr. Top. Med. Chem. 2:2002;1239-1259
9. Urbina J.A. Curr. Opin. Anti-infect. Invest. Drugs. 2:2000;40-46
10. Suresh S., Turley S., Opperdoes F.R., Michels P.A.M., Hol W.G.J. Structure. 8:2000;541-552
11. Cerecetto H., González M. Curr. Top. Med. Chem. 2:2002;1185-1211
12. Nozaki T., Engel J., Dvorak J. Am. J. Trop. Med. Hyg. 55:1996;111-117
13. Murta S.M., Romanha A.J. Parasitology. 116:1998;165-171
14. Fairlamb A.H., Cerami A. Annu. Rev. Microbiol. 46:1992;695-729
15. Hunter W.N., Bailey S., Habash J., et al. J. Mol. Biol. 227:1992;322-333
16. Lantwin C.B., Schlichting I., Kabsch W., Pai E.F., Krauth-Siegel R.L. Proteins. 18:1994;161-173
17. Bailey S., Smith K., Fairlamb A.H., Hunter W.N. Eur. J. Biochem. 213:1993;67-75
18. Bond C.S., Zhang Y., Berriman M., Cunningham M.L., Fairlamb A.H., Hunter W.N. Struct. Fold Des. 7:1999;81-89
19. Jacoby E.M., Schlichting I., Lantwin C.B., Kabsch W., Krauth-Siegel R.L. Proteins. 24:1996;73-80
20. Krauth-Siegel R.L., Lohrer H., Bücheler U.S., Schirmer R.H. Coombs G., North M. Biochemical Protozoology. 1991;493-506 Taylor & Francis, London
21. Benson T.J., McKie J.H., Garforth J., Borges A., Fairlamb A.H., Douglas K.T. Biochem. J. 286:1992;9-11
22. Khan M.O., Austin S.E., Chan C., et al. J. Med. Chem. 43:2000;3148-3156
23. Cerecetto H., González M. Mini Rev. Med. Chem. 1:2001;219-231
24. Cerecetto H., Di Maio R., González M., et al. J. Med. Chem. 42:1999;1941-1945
25. Aldana I., Ortega M.A., Jaso A., et al. Pharmazie. 58:2003;68-69
26. Zarranz B., Jaso A., Aldana I., Monge A. Bioorg. Med. Chem. 11:2003;2149-2156
27. 13C NMR and HETCOR experiments, and their purity established by TLC and microanalysis
28. Monge A., Martínez-Crespo F.J., López de Ceráin A., et al. J. Med. Chem. 38:1995;4488-4494
29. Monge A., Palop J.A., González M., et al. J. Heterocycl. Chem. 32:1995;1213-1217
30. Cerecetto H., Dias E., Di Maio R., et al. J. Agric. Food Chem. 48:2000;2995-3002
31. Ortega M.A., Morancho M.J., Martínez-Crespo F.J., et al. Eur. J. Med. Chem. 35:2000;21-30
32. Monge A., Palop J.A., Piñol A., et al. J. Heterocycl. Chem. 31:1994;1135-1139
33. Cerecetto H., Di Maio R., Ibarruri G., et al. Farmaco. 53:1998;89-94
34. Denicola A., Rubbo H., Rodríguez D., Radi R. Arch. Biochem. Biophys. 304:1993;279-286
35. 6 cells/mL. Cell growth was followed by measuring everyday the absorbance of the culture at 600 nm. Before inoculation, the media was supplemented with the indicated amount of the drug from a stock solution in DMSO. The final concentration of DMSO in the culture media never exceeded 0.4% and the control was run in the presence of 0.4% DMSO and in the absence of any drug. No effect on epimastigotes growth was observed by the presence of up to 1% DMSO in the culture media. Growth of the parasite was followed for 11 days by measuring the increase in absorbance at 600 nm, which was proved to be proportional to the number of cells present.
36. 600 in the absence of the drug at day 0
37. 20 Compounds were constructed and studied as 7-substituted derivatives. The energy of each compound was minimised by molecular mechanics methods (using SYBYL molecular mechanics force fields implemented in PC SPARTAN Pro package) and then by semiempirical methods (AM1). With the structure of minimum energy a single point calculation were performed using AM1 semiempirical method implemented in the package. LogP calculated (CLogP) by Villar algorithm implemented in PC SPARTAN Pro package was used
38. Wavefunction Inc., 18401 Von Karman Avenue, Suite 370. Irvine, California 92612 USA
39. PC SPARTAN Pro User's Guide, Wavefunction Inc., California, 1999
40. 2=0.685, n=11.
41. 2 1
42. Caron G., Carrupt P.A., Testa B., Ermondi G., Gasco A. Pharm. Res. 13:1996;1186-1190
43. Myers R.H. Classical and Modern Regression with Application. 1986;P.W.S. Publishers, Boston
44. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Adv. Drug Deliv. Rev. 23:1997;3-25